DeepThink PTB vs OM336AIC1001
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
DeepThink PTB
This medical app helps oncologists interpret complex tumor data and identify precision therapies. It facilitates collaboration among tumor board members and provides access to FDA-approved treatments and clinical trials.
- Interpret genomic tumor reports
- Identify FDA-approved therapies
- Suggest targeted therapies
- Screen clinical trials
- Collaborate with tumor board members
- Schedule virtual meetings
Read full descriptionHide full description
DeepThink Health Precision Tumor Board ™ Advancing medicine with precision intelligence ™ DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Just as in the desktop Precision Tumor Board application, in our mobile app we’ve integrated and processed a cancer patient’s molecular/genomic tumor report enabling Molecular Tumor Board and Standard Tumor Board to quickly interpret the complex data for oncologists urgently needing to prescribe the right therapies for their cancer patients. Tumor Board members can: • Quickly see FDA approved therapies with predictive responses for the patient’s specific tumor type and genetic characteristics • Easily select among targeted therapies based on biomarkers or suggest therapies to enhance the molecular report interpretation • See clinical trials already screened for the patient case in context • Collaborate with other Molecular Tumor Board members to quickly and timely provide a succinct report to the treating oncologist • Schedule and hold virtual tumor board meeting • No private health information is stored or relayed in the application, DeepThink Health products are HIPAA compliant. About DeepThink Health DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Our team has extensive experience and success in leading Healthcare IT companies serving providers, payers and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been successfully implemented at large Healthcare IDNs where the combined genomic, clinical and outcome data were analyzed using DeepThink Artificial Intelligence tools to advance precision medicine and enable novel discoveries.
OM336AIC1001
Read full descriptionHide full description
This app is intended for use by participants in the OM336-AIC-1001 study and requires an invitation and activation code from the study site to register, An Open-Label, Phase 1b, Multiple Ascending Dose Study of OM336 in Participants with Active Autoimmune Cytopenias. This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Key App Features: - Patient Onboarding – complete study app registration and education - Activities – complete scheduled or on-demand study tasks and assessments - Dashboard – review overall progress in the study and current activities - Resources – view study information in the Learn section of the app - Profile – manage account details and app settings - Notifications – receive in-app reminders - Telehealth – conduct scheduled virtual visits with your study site About THREAD: THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient.
Screenshots
Verdict
The clearest difference is iOS requirement: DeepThink PTB at 9.2 against OM336AIC1001's 15.5. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
DeepThink PTB ships an update every 2 months, OM336AIC1001 every 3 months. The most recent releases landed on November 3, 2026 and November 12, 2026 respectively.
| Parameter | DeepThink PTB | OM336AIC1001 |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (4 ratings) — better | — |
| Number of ratings | 4 — better | — |
| Update frequency | Every 2 months — better | Every 3 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 9.2 — better | 15.5 |
| Further details — not scored | ||
| Size | 34 MB | 57 MB |
| Age rating | 17+ | 17+ |
| Developer | Deepthink Health, Inc | Hello Thread |
In-app purchases
DeepThink PTB
No in-app purchases
OM336AIC1001
No in-app purchases








